Rebecca Nance, NP
Family · Boonville, INNPI 1295138949
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 85.2% of it on its own, with 26 other manufacturers making up the rest. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $90.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$35K
- AbbVie$814
- Johnson & Johnson$690
- Sunovion Pharmaceuticals Inc.$627
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$595
- Otsuka America Pharmaceutical, Inc.$437
- plus $3K from 21 others
What the payments were for
- Consulting fees$19,00046%
- Speaking & faculty fees$11,50028%
- Travel & lodging$3,1848%
- Food & beverage$7,61718%
- Education$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 58 | $35,247 |
| AbbVie | 47 | $814 |
| Johnson & Johnson | 43 | $690 |
| Sunovion Pharmaceuticals Inc. | 84 | $627 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $595 |
| Otsuka America Pharmaceutical, Inc. | 17 | $437 |
| Supernus Pharmaceuticals, Inc. | 27 | $355 |
| Corium, LLC | 21 | $293 |
| Vanda Pharmaceuticals Inc. | 15 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $243 |
| Neos Therapeutics, LP | 13 | $232 |
| Bausch Health US, LLC | 14 | $221 |
| Lundbeck LLC | 15 | $194 |
| Tris Pharma Inc | 11 | $190 |
| Harmony Biosciences LLC | 6 | $138 |
| Jazz Pharmaceuticals Inc. | 3 | $127 |
| Alkermes, Inc. | 7 | $127 |
| Teva Pharmaceuticals USA, Inc. | 7 | $124 |
| Ironshore Pharmaceuticals Inc. | 14 | $119 |
| Neurocrine Biosciences, Inc. | 4 | $113 |
| Indivior Inc. | 5 | $72 |
| Biogen | 1 | $64 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,355 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluoxetine Hcl | 24 | $1,865 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,380 |
| Lamotrigine | 49 | $1,247 |
| Buspirone Hcl | 17 | $407 |
| Clonazepam | 15 | $79 |
Paid to pharmacies, not to this prescriber.
Other family in Boonville
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.